0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Form:
Liquid (sterile filtered)
Target:
Human
Antibody Type:
Primary Antibody
Application Dilute:
IHC: 5µg/mL, WB: 1-4µg/mL
Application Notes:
Anti-IL-23 Antibody is tested for use in E, WB, IF, IHC, and ICC. Expect a band approximately ~20.7 kDa on specific lysates. Western Blot, Immunocytochemistry, Immunofluorescence and Immunohistochemistry tested in human samples. Specific conditions for r
Immunocytochemistry of IL-23. Cell: Raji cells. Fixation: formaldehyde and blocked with 10% serum for 1 h at RT. Antigen retrieval: heat mediation with a citrate buffer (pH6). Primary Antibody: anti-IL-23 antibody at 10 µg/ml overnight at 4C. Secondary: goat anti-rabbit IgG H&L (HRP) at 1:250. Counter stained with Hematoxylin.
Immunofluorescence Validation of IL-23. Tissue: Human Pancreas Tissue. Fixation: 4% paraformaldehyde-fixed. Primary Antibody: Anti-IL-23 at 20 µg/mL. Secondary Antibody: goat anti-rabbit IgG secondary antibody at 1:500 dilution (red) and DAPI staining (blue).
Immunohistochemistry Validation of IL-23. Tissue: Human Pancreas Tissue. Fixation: paraffin-embedded, formaldehyde and blocked with 10% serum for 1 h at RT. Antigen retrieval: heat mediation with a citrate buffer (pH6). Primary antibody: anti-IL-23 antibody at 5 µg/ml overnight at 4 C. Secondary: goat anti-rabbit IgG H&L (HRP) at 1:250. Counter stained with Hematoxylin.
Western Blot Validation of IL-23. Load: 15 µg of Human Raji Cell lysates per lane.Primary antibody: anti-IL-23 at 1µg/mL in (Lane A: the absence of blocking peptide or Lane B: the presence of blocking peptide) for 1h at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Immunofluorescence Validation of IL-23. Cell: Raji Cells. Fixation: 4% paraformaldehyde-fixed. Primary Antibody: Anti-IL-23 at 20 µg/mL. Secondary: goat anti-rabbit IgG secondary antibody at 1:500 dilution (red).
Western Blot Validation of IL-23. Load: 20 µg of human lysates per lane. Lane 1: Daudi, Lane 2: K562, Lane 3: MCF7, Lane 4: THP-1. Primary antibody: anti-IL-23 at 2µg/mL for 1h at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Western Blot Validation of IL-23 with Recombinant Protein. Load: 30 ng of human IL-23 recombinant protein. Primary antibody: anti-IL-23 at 4µg/mL for 1h at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
* VAT and and shipping costs not included. Errors and price changes excepted